NKOSF yields 4210.53% · PFE yields 6.13%● Live data
📍 NKOSF pulled ahead of the other in Year 1
Combined, NKOSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NKOSF + PFE for your $10,000?
Labrador Gold Corp. engages in the acquisition, exploration, and development of gold properties in the Americas. The company owns a 100% interest in the Borden Lake property that covers an area of 1,598-hectares located in Chapleau, Ontario. It has an option to acquire 100% interest in the Ashuanipi property consisting of 1,564 Claims in 10 claim blocks covering an area of approximately 391 square kilometers located in Labrador, Quebec; the Kingsway property consisting of 264 claims in 3 licenses covering approximately 77 square kilometers located near Gander, Newfoundland; and the Hopedale property that comprises 998 claims in 5 licenses covering 249 square kilometers. The company was formerly known as Nikos Explorations Ltd. and changed its name to Labrador Gold Corp. in December 2017. Labrador Gold Corp. was incorporated in 1987 and is headquartered in Toronto, Canada.
Full NKOSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.